SCHEMBL3441264

SCHEMBL3441264

CCn1c(=O)c(CS(=O)(=O)Cc2ccc(Cl)cc2)nc2ccccc21.CCn1c(=O)c(CS(=O)(=O)Cc2ccccc2)nc2ccccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 3/20 0.57
MAPK1 P28482 2/20 0.57
HPGD P15428 2/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 1/20 0.57
PDE4A P27815 1/20 0.54
PDE4B Q07343 1/20 0.54
PDE4C Q08493 1/20 0.54
PDE4D Q08499 1/20 0.54
GALR3 O60755 1/20 0.47
NR2F2 P24468 1/20 0.47
RAB9A P51151 1/20 0.47
S1PR1 P21453 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL983167 0.99 MAPK1 (0.59) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL979976 0.93 KDM4E (0.66) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL985091 0.83 MAPK1 (0.66) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL982699 0.77 KDM4E (0.68) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL982499 0.76 MAPK1 (0.75) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL981898 0.74 KDM4E (1.00) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL981117 0.73 ALDH1A1 (0.61) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL979635 0.73 CFTR (0.64) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL980624 0.72 KDM4E (0.77) ALDH1A1KDM4EMAPK1HPGDHSD17B10
SCHEMBL979729 0.72 MAPK1 (0.68) ALDH1A1KDM4EMAPK1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247580-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES Merck Patent GmbH (DE) 2010-11-10 EP claimed
WO-2009109258-A1 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES MERCK PATENT GMBH (DE) 2009-09-11 WO claimed